Zdrowie i gospodarka · 25/04/2019

FDA Releases Draft Guidance on Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biologics

The US Food and Drug Administration (FDA) has published a draft guidance document outlining its approach to adjusting for covariates in clinical trials for pharmaceuticals and biologics with continuous outcomes, with the aim of finalizing the guidance in the near future.